Area of research
Cognitive Neuroscience · Electrical and Electronic Engineering
Research interest
Research interests include EEG and Brain-Computer Interfaces, Functional Brain Connectivity Studies, Advanced Memory and Neural Computing, and Sleep and Work-Related Fatigue.
Resting-state fMRI foundation models enable robust and generalizable latent neural target discovery in cognitive aging interventions
Hybrid spiking neural network for sleep electroencephalogram signals
SATP-GAN: self-attention based generative adversarial network for traffic flow prediction
The Prognostic Value of Baseline Distant Metastasis in Icotinib-Treated Patients with EGFR-Mutated Stage IV Non-Small Cell Lung Cancer
The relationships between cancer diagnosis/prognosis awareness and quality of life, anxiety, and depression in Chinese gastroesophageal cancer patients: A cross-correlation analysis.
Efficacy and safety of anlotinib in the treatment of lung cancer.
The clinicopathological characteristics, gene mutation characteristics and survival analysis of carcinoma of unknown primary origin.
Studies on the efficacy of pyrotinib in the treatment of HER-2 positive advanced solid tumors.
Specific organ metastases and survival of advanced non-small cell lung cancer (NSCLC) patients with EGFR mutation.
The clinical significance of gabapentin in combination with opioids in controlling outbreak of pain in cancer patients.
miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer
Flotillin1 promotes EMT of human small cell lung cancer via TGF-β signaling pathway
The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression
miR-210 regulates esophageal cancer cell proliferation by inducing G2/M phase cell cycle arrest through targeting PLK1
LIM-domain-only proteins: multifunctional nuclear transcription coregulators that interacts with diverse proteins
Multiple<i>MAGE-A</i>genes as surveillance marker for the detection of circulating tumor cells in patients with ovarian cancer
LMO4 inhibits p53-mediated proliferative inhibition of breast cancer cells through interacting p53